Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Factor XIIIa is the active form of coagulation factor XIII, a transglutaminase enzyme crucial for the final stages of blood clotting. It catalyzes the formation of covalent cross-links between fibrin molecules, stabilizing blood clots and protecting them from premature breakdown. It plays roles in wound healing, tissue repair, angiogenesis, and other intracellular processes. Deficiency leads to severe bleeding diathesis.
Catalyzes the formation of covalent cross-links between fibrin molecules, stabilizing blood clots.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coagulation Factor XIII A Chain (FXIIIa).